O
CMPS

OrbiMed’s Compass Pathways CMPS Stock Holding History

OrbiMed’s Portfolio CMPS Stock Details CMPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.36M Buy
+1,150,646
New +$7.74M 0.13% 88
2021
Q2 		– Sell
-127,816
Closed -$4.71M – 163
2021
Q1 		$4.71M Sell
127,816
-222,184
-63% -$9.74M 0.04% 146
2020
Q4 		$16.7M Hold
350,000
– – 0.15% 109
2020
Q3 		$12.2M Buy
+350,000
New +$12.6M 0.15% 103

Other funds holding CMPS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

OrbiMed's CMPS Position: Q1 2026 in Review

OrbiMed opened a new position in Compass Pathways (CMPS) in Q1 2026: 1,150,646 shares worth $6.36M. The stake represents 0.13% of the portfolio and ranks #88 among its holdings. This is a return to the name: OrbiMed previously reported a position in CMPS as recently as Q1 2021.

OrbiMed first reported a position in CMPS in Q3 2020 and has held it in 4 quarters since. The position peaked at $16.7M in Q4 2020. 194 funds tracked by Wall St. Rank hold CMPS as of Q1 2026.

  • OrbiMed held 1,150,646 shares of Compass Pathways worth $6.36M as of Q1 2026.
  • Compass Pathways was a new OrbiMed position in Q1 2026.
  • Compass Pathways made up 0.13% of OrbiMed's portfolio in Q1 2026, its #88 holding.
  • OrbiMed first reported a position in Compass Pathways in Q3 2020 and has held it in 4 quarters since.
  • OrbiMed's Compass Pathways position peaked at $16.7M in Q4 2020.
  • 194 funds tracked by Wall St. Rank held Compass Pathways as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.